Chang Shu
- Cancer Research top 5%
- MicroRNA in disease regulation 8
- Cancer, Hypoxia, and Metabolism 7
- Genetics top 5%
- Glioma Diagnosis and Treatment 11
- Infectious Diseases top 10%
- General Dentistry top 10%
- Organic Chemistry top 10%
- Asymmetric Synthesis and Catalysis 7
-
- Acute Ischemic Stroke Management 5
-
- Circular RNAs in diseases 5
-
- Nutritional Studies and Diet 4
-
- Hepatocellular Carcinoma Treatment and Prognosis 4
Chang Shu
69 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 149
- Cancer Research 398
- Genetics 172
- Infectious Diseases 231
- General Dentistry 21
- Organic Chemistry 287
Countries citing papers authored by Chang Shu
This map shows the geographic impact of Chang Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang Shu more than expected).
Fields of papers citing papers by Chang Shu
This network shows the impact of papers produced by Chang Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang Shu. The network helps show where Chang Shu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chang Shu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 20 | |
| 7 | 2022 | 6 | |
| 8 | 2022 | 1 | |
| 9 | 2021 | 76 | |
| 10 | 2020 | 281 | |
| 11 | 2020 | 27 | |
| 12 | 2019 | 44 | |
| 13 | 2019 | 11 | |
| 14 | 2018 | 5 | |
| 15 | 2018 | 10 | |
| 16 | 2017 | 34 | |
| 17 | 2017 | 87 | |
| 18 | 2016 | 16 | |
| 19 | 2016 | 23 | |
| 20 | 2015 | 48 |
About Chang Shu
Chang Shu is a scholar working on Cancer Research, Genetics and Hepatology, having authored 73 papers that have together received 1.8k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (11 papers), MicroRNA in disease regulation (8 papers), Asymmetric Synthesis and Catalysis (7 papers), Cancer, Hypoxia, and Metabolism (7 papers), Acute Ischemic Stroke Management (5 papers), Circular RNAs in diseases (5 papers), Nutritional Studies and Diet (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). The work is most often cited by research in Cancer Research (398 citations), Genetics (172 citations) and Infectious Diseases (231 citations). Chang Shu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Jinhuan Wang, Wei‐Cheng Yuan, Xiaomei Zhang, Quanfeng Ma, Jikui Sun, Banban Li, Georg Karpel‐Massler, Markus D. Siegelin, Cao Chen and Dongyan Wang. Their work appears in journals such as Angewandte Chemie International Edition, Nature Communications and Molecular Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.